Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255902 | SCV000322471 | pathogenic | not provided | 2019-12-11 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate an impairment of the calcium release channel function and regulation at the Asn4806 residue (Du et al., 1998); Not observed in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 22473935, 28818389, 27234031, 9822655) |
Prevention |
RCV000255902 | SCV000852410 | likely pathogenic | not provided | 2015-08-07 | criteria provided, single submitter | clinical testing | |
Genomic Research Center, |
RCV000784911 | SCV000923452 | pathogenic | not specified | 2024-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001047738 | SCV001211718 | pathogenic | RYR1-related disorder | 2022-10-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function. ClinVar contains an entry for this variant (Variation ID: 265505). This missense change has been observed in individuals with autosomal recessive RYR1-related conditions (PMID: 22473935, 25960145, 27234031, 28818389). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces asparagine, which is neutral and polar, with aspartic acid, which is acidic and polar, at codon 4806 of the RYR1 protein (p.Asn4806Asp). |
Kariminejad - |
RCV001814134 | SCV001755574 | pathogenic | Abnormality of the musculature | 2021-07-10 | criteria provided, single submitter | clinical testing | |
Ai |
RCV000255902 | SCV002501371 | likely pathogenic | not provided | 2021-05-16 | criteria provided, single submitter | clinical testing | |
Department of Genetics, |
RCV003761884 | SCV004543859 | pathogenic | RYR1-related myopathy | 2023-01-16 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000255902 | SCV000331383 | uncertain significance | not provided | 2015-10-19 | flagged submission | clinical testing |